Swiss pharmaceutical company Biogen has won discovery of documents sent from Sandoz to the Therapeutic Goods Administration, as it weighs a third patent infringement lawsuit to protect its multiple sclerosis drug against generic reproductions.
Swiss pharmaceutical company Biogen is considering a third patent infringement lawsuit against a drug maker to shield its monopoly in Australia for blockbuster multiple sclerosis drug Tecfidera from generic competition.
An alternative therapies clinic in Victoria has been hit with $3 million in penalties for allegedly promoting āpseudo-scientificā treatments to vulnerable people with chronic illnesses in posts on social media and its website.
Construction equipment giant Caterpillar has resolved its dispute with a former employee accused of flagrantly copying “many thousands” of confidential files before taking a job with a competitor.
Melbourne-based joint venture Shepparton Partners Collective has lost its appeal of a $1.2 million judgment that found it infringed software developer QAD’s copyright by failing to pay a transfer fee to retain the licence after it acquired the iconic SPC Ardmona cannery in Victoria from Coca-Cola Amatil for $40 million.
The maker of Somat dishwashing products has hit back at allegations of trade mark infringement, telling a court the prominent brand name on its range of dishwashing tablets functions as an āunmistakableā point of difference between the company and market leader Finish.
Australian rock band Little River Band has secured an injunction against an Adelaide-based record label accused of hijacking the bandās Spotify accounts on behalf of disgruntled former band members.
Nine Network, Seven Network and the Australian Broadcasting Corporation have won a temporary injunction barring the Civil Aviation Safety Authority from declaring the area above the Melbourne CBD to be a restricted area in response to anti-lockdown and anti-vaccine protests that have disrupted the city.
Truck company Isuzu has asked a court to shut down an $18 million lawsuit by Directed Electronics alleging copyright infringement, arguing that its own cross-claims –which substantially overlap with allegations in a 2017 case that went to trial — made it an abuse of process.
Swiss pharmaceutical company Biogen is seeking a court order blocking an Australian generic drug manufacturer from selling a cheap multiple sclerosis drug it claims infringes its patent for medicine Tecfidera, a court has heard.